Article info

Download PDFPDF
125
DISEASE MODIFYING TREATMENT UTILISATION IN MULTIPLE SCLEROSIS

Authors

  • Owain H Williams Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, UHW, Cardiff, UK Department of Neurology, Helen Durham Centre for Neuroinflammatory Disease, UHW, Cardiff, UK PubMed articlesGoogle scholar articles
  • Katharine E Harding Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, UHW, Cardiff, UK Department of Neurology, Helen Durham Centre for Neuroinflammatory Disease, UHW, Cardiff, UK PubMed articlesGoogle scholar articles
  • Mark Willis Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, UHW, Cardiff, UK Department of Neurology, Helen Durham Centre for Neuroinflammatory Disease, UHW, Cardiff, UK PubMed articlesGoogle scholar articles
  • Trevor Pickersgill Department of Neurology, Helen Durham Centre for Neuroinflammatory Disease, UHW, Cardiff, UK PubMed articlesGoogle scholar articles
  • Mark Wardle Department of Neurology, Helen Durham Centre for Neuroinflammatory Disease, UHW, Cardiff, UK PubMed articlesGoogle scholar articles
  • Neil P Robertson Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, UHW, Cardiff, UK Department of Neurology, Helen Durham Centre for Neuroinflammatory Disease, UHW, Cardiff, UK PubMed articlesGoogle scholar articles

Citation

Williams OH, Harding KE, Willis M, et al
DISEASE MODIFYING TREATMENT UTILISATION IN MULTIPLE SCLEROSIS

Publication history

  • First published October 14, 2015.
Online issue publication 
April 11, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.